NNMT acts as a negative regulator of intracellular SAM: its overexpression in CRC cells reduces SAM and global methylation while elevating SAH, thereby increasing the sensitivity of CRC cells to OXPHOS inhibitors (188). This evidence concerns the gene NNMT and colorectal carcinoma.